郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Fluorescent ligands for dopamine D2/D3 receptors.

期刊：Scientific reports发表年份：2020作者：Anni Allikalt; Nirupam Purkayastha; Khajidmaa Flad; Maximilian F Schmidt; Alina Tabor; Peter Gmeiner; Harald Hübner; Dorothee Weikert
阅读更多 →

药效评价Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2020作者：Ashvani K Singh; Yihong Fan; Corina Balut; Sara Alani; Arlene M Manelli; Andrew M Swensen; Ying Jia; Torben R Neelands; Timothy A Vortherms; Bo Liu; Xenia B Searle; Xueqing Wang; Wenqing Gao; Tzyh-Chang Hwang; Hong Y Ren; Douglas Cyr; Philip R Kym; K
阅读更多 →

药效评价Fenfluramine acts as a positive modulator of sigma-1 receptors.

期刊：Epilepsy & behavior : E&B发表年份：2020作者：Parthena Martin; Peter A M de Witte; Tangui Maurice; Arnold Gammaitoni; Gail Farfel; Bradley Galer
阅读更多 →

药效评价Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration.

期刊：Psychopharmacology发表年份：2020作者：Glenn W Stevenson; Denise Giuvelis; James Cormier; Katherine Cone; Phillip Atherton; Rebecca Krivitsky; Emily Warner; Brooke St Laurent; Julio Dutra; Jean M Bidlack; Lajos Szabò; Robin Polt; Edward J Bilsky
阅读更多 →